Copyright
©The Author(s) 2022.
World J Diabetes. Nov 15, 2022; 13(11): 986-1000
Published online Nov 15, 2022. doi: 10.4239/wjd.v13.i11.986
Published online Nov 15, 2022. doi: 10.4239/wjd.v13.i11.986
Table 1 Univariate analysis of risk factors for diabetic retinopathy or proliferative diabetic retinopathy
Variable | WDR group (n = 826) | DR group (n = 828) | NPDR group (n = 403) | PDR group (n = 425) | P value1 | P value2 |
Age (yr) | 53.9 ± 10.3 | 54.9 ± 10.7 | 56.2 ± 10.9 | 53.6 ± 10.3 | 0.056 | < 0.001 |
Sex (male/female) | 487/339 | 424/404 | 238/165 | 186/239 | 0.002 | < 0.001 |
Diabetes duration (yr) | 6.9 ± 5.2 | 11.2 ± 6.8 | 10.9 ± 7.1 | 11.4 ± 6.4 | < 0.001 | 0.221 |
Height (cm) | 165.2 ± 8.3 | 162.5 ± 8.3 | 164.2 ± 8.5 | 160.8 ± 7.8 | < 0.001 | < 0.001 |
Weight (kg) | 68.1 ± 11.7 | 64.2 ± 11.3 | 65.7 ± 11.5 | 62.8 ± 10.9 | < 0.001 | < 0.001 |
BMI (kg/m2) | 24.9 ± 3.3 | 24.3 ± 3.4 | 24.3 ± 3.3 | 24.2 ± 3.5 | < 0.001 | 0.880 |
Waist circumference (cm) | 90.8 ± 9.5 | 89.9 ± 10.0 | 90.2 ± 9.7 | 89.6 ± 10.3 | 0.060 | 0.399 |
Hip circumference (cm) | 97.6 ± 7.6 | 95.9 ± 7.4 | 96.4 ± 7.2 | 95.4 ± 7.6 | < 0.001 | 0.046 |
WHR | 1.0 ± 0.5 | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.284 | 0.092 |
Standing SBP (mmHg) | 129.0 ± 16.9 | 136.4 ± 22.9 | 135.9 ± 22.6 | 136.9 ± 23.2 | < 0.001 | 0.517 |
Standing DBP (mmHg) | 83.4 ± 11.6 | 83.8 ± 13.4 | 83.5 ± 13.0 | 84.0 ± 13.7 | 0.501 | 0.578 |
Supine SBP (mmHg) | 130.1 ± 16.3 | 141.0 ± 21.3 | 139.4 ± 20.6 | 142.4 ± 22.0 | < 0.001 | 0.045 |
Supine DBP (mmHg) | 82.6 ± 11.2 | 85.0 ± 12.3 | 83.9±12.0 | 86.1 ± 12.4 | < 0.001 | 0.012 |
Glu0 (mmol/L) | 9.4 ± 3.3 | 9.9 ± 3.7 | 10.0 ± 3.7 | 9.8 ± 3.7 | 0.008 | 0.647 |
HbA1c (%) | 9.1 ± 2.5 | 9.8 ± 2.4 | 9.9 ± 2.5 | 9.7 ± 2.3 | < 0.001 | 0.402 |
Chol (mmol/L) | 4.4 ± 1.5 | 5.0 ± 1.5 | 4.8 ± 1.5 | 5.1 ± 1.4 | < 0.001 | 0.013 |
Trig (mmol/L) | 2.8 ± 2.3 | 2.6 ± 2.4 | 2.6 ± 2.5 | 2.6 ± 2.4 | 0.033 | 0.856 |
HDL-C (mmol/L) | 1.1 ± 0.3 | 1.1 ± 0.3 | 1.1 ± 0.3 | 1.1 ± 0.4 | 0.057 | 0.095 |
LDL-C (mmol/L) | 2.9 ± 0.9 | 3.0 ± 1.0 | 2.9 ± 1.0 | 3.1 ± 1.1 | 0.101 | 0.004 |
BUN (μmol/L) | 5.1 ± 1.7 | 6.6 ± 2.8 | 6.4 ± 2.8 | 6.8 ± 2.8 | < 0.001 | 0.021 |
UA (μmol/L) | 347.6 ± 103.4 | 359.4 ± 102.0 | 355.4 ± 106.4 | 363.2 ± 97.6 | 0.019 | 0.270 |
Scr (μmol/L) | 69.8 ± 28.3 | 90.0 ± 61.8 | 86.0 ± 64.1 | 93.9 ± 59.4 | < 0.001 | 0.068 |
eGFR (mL/min) | 116.9 ± 37.3 | 98.3 ± 42.4 | 103.5 ± 40.9 | 93.3 ± 43.2 | < 0.001 | 0.001 |
- Citation: Zhou YY, Zhou TC, Chen N, Zhou GZ, Zhou HJ, Li XD, Wang JR, Bai CF, Long R, Xiong YX, Yang Y. Risk factor analysis and clinical decision tree model construction for diabetic retinopathy in Western China. World J Diabetes 2022; 13(11): 986-1000
- URL: https://www.wjgnet.com/1948-9358/full/v13/i11/986.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i11.986